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We have previously shown that retinoic acid receptor (RAR) stimulation by an agonist Am80 recruits
nitric oxide-dependent signaling via increased expression of neuronal nitric oxide synthase (nNOS) in rat
midbrain slice cultures. Using neuroblastoma SH-SY5Y cells, here we investigated the mechanisms of
RAR-induced nNOS expression, together with relationship between nNOS expression and neurite
outgrowth. Am80 promoted neurite outgrowth, which was attenuated by inhibitors of phosphoinositide
3-kinase (PI3K; LY294002), c-Jun N-terminal kinase (JNK; SP600125) and p38 mitogen-activated protein
kinase (p38 MAPK; SB203580). A selective nNOS inhibitor 3-bromo-nitroindazole also suppressed Am80-
induced neurite outgrowth. Am80-induced increase in nNOS protein expression was attenuated by
LY294002, SP600125 and SB203580, whereas increase in nNOS mRNA expression was attenuated only by
LY294002. Am80-induced activation of JNK and p38 MAPK was blocked by LY294002, suggesting that
these kinases acted downstream of PI3K. We also conﬁrmed that DAX1, a nuclear receptor reported to
regulate nNOS expression, was up-regulated in response to Am80. siRNA-mediated knockdown of DAX1
abrogated Am80-induced nNOS expression and neurite outgrowth. These results reveal for the ﬁrst time
that nNOS expression is crucial for RAR-mediated neurite outgrowth, and that non-genomic signaling
such as JNK and p38 MAPK is involved in RAR-mediated nNOS expression.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Retinoic acid, key morphogen during embryonic develop-
ment, plays a fundamental role in construction of the architec-
ture of various organs including the central nervous system (1).
Retinoic acid receptors (RARs) are primarily responsible for
transducing various biological actions of retinoic acid. Ligand-o-Pharmacological Sciences,
umamoto University, 5-1
n. Tel.: þ81 96 371 4180;
H. Katsuki).
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).bound RARs, forming heterodimers with retinoid X receptors,
associate with speciﬁc DNA sequences named retinoic acid-
responsive element (RARE), and regulate expression of down-
stream genes. In addition to this classical mechanism of
signaling, non-genomic signaling pathways such as phosphoi-
nositide 3-kinase (PI3K) pathway and mitogen-activated protein
kinase (MAPK) pathways may be recruited in response to RAR
stimulation (2).
Increasing lines of evidence indicate that RARs are also involved
in various physiological functions of the central nervous system,
such as neurotransmission, plasticity and neuroprotection (3,4).
Previously we have addressed the role of RARs with relation to
protection and survival of midbrain dopaminergic neurons. A
synthetic RARa/b agonist Am80 was found to protect dopaminergicnese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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degeneration (5). Moreover, we have revealed that increased
expression of brain-derived neurotrophic factor (BDNF) underlies
the protective effect of Am80 on dopaminergic neurons (5). Sub-
sequent investigation on the signaling mechanisms linking RAR
stimulation to BDNF up-regulation demonstrated that the expres-
sion level of neuronal nitric oxide synthase (nNOS)was increased in
response to Am80, and that resultant recruitment of nitric oxide
(NO)/cyclic GMP signaling played a pivotal role in BDNF
expression (6).
nNOS gene expression receives complex regulation (7), but
direct RARE-mediated transcriptional control has not been identi-
ﬁed. Therefore, non-classical signaling mechanisms are considered
to mediate RAR-induced nNOS up-regulation. In this context,
neuroblastoma cell linesmay serve a convenientmodel to study the
regulatory mechanisms of nNOS expression. Indeed, retinoic acid-
induced increase in NO production or nNOS expression has been
observed in several cell lines such as SN56 (8) and TGW-nu-I (9). In
TGW-nu-I neuroblastoma, themechanisms of retinoic acid-induced
nNOS expression have been examined in some detail, and
involvement of PI3K and a nuclear receptor DAX1 has been
revealed (9). On the other hand, another neuroblastoma cell line
SH-SY5Y is well known to undergo neuron-like differentiation in
response to retinoic acid application, which is characterized by
outgrowth of neuritic processes (10,11). However, nNOS
up-regulation by retinoid signaling has not been reported in this
cell line.
Herewe report that RAR stimulation by Am80 leads to increased
nNOS expression in SH-SY5Y cells, which is causally related to
neurite outgrowth. We also addressed potential involvement of
several non-classical RAR signaling components in nNOS up-
regulation.2. Materials and methods
2.1. Drugs
Drugs (enzyme inhibitors) used in the present study were
SP600125 (#BML-EI305, Enzo Life Sciences, Farmingdale, NY, USA),
SB203580 (#13067, Cayman Chemical, Ann Arbor, MI, USA),
PD98059 (#1006726, Cayman Chemical), LY294002 (#L9908, Sig-
maeAldrich, St. Louis, MO, USA) and 3-bromo-7-nitroindazole
(#sc-200347, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA).
These inhibitors at concentrations used in the present study did not
affect the viability of SH-SY5Y cells appreciably. Am80 was syn-
thesized as described previously (12).2.2. SH-SY5Y cell cultures and drug treatment
Human neuroblastoma SH-SY5Y cells were obtained from the
American Type Culture Collection (Manassas, VA, USA) and main-
tained in a 1:1 mixture of Ham's F-12 and Dulbecco's modiﬁed
Eagle's medium supplemented with 10% fetal bovine serum, 2 mM
L-glutamine and 100 U/ml penicillin-G/100 mg/ml streptomycin in a
37 C, 5% CO2 humidiﬁed atmosphere. Cells were plated onto non-
coated 35 mm dish at a density of 6.0  104 cells/cm2 (for Western
blotting and RT-PCR), or at a density of 1.5  104 cells/cm2 (for
neurite outgrowth assay). Twenty four hours after plating, medium
was replaced with serum-free one consisting of Neurobasal-A
medium (#10888-022, Life Technologies, Tokyo, Japan) with
0.5 mM L-glutamine and 2% B-27 supplement minus vitamin A
(#12587-010, Life Technologies). Am80 was added to the serum-
free medium, after 1 h of pretreatment with enzyme inhibitors.2.3. Assessment of neurite outgrowth
After 24 h of treatment with Am80, four phase-contrast images
of cells at 200 magniﬁcation were obtained at random from each
35mmdish. Neurite lengths of all cells within the photo ﬁelds were
quantiﬁed from these images with the use of NIH ImageJ software
with NeuronJ plug-in.2.4. Western blotting
After drug treatment for indicated periods, SH-SY5Y cells were
collected in lysis buffer and centrifuged at 14,000 g at 4 C for
30min. With sample buffer containing 0.5 M TriseHCl (pH 6.8), 10%
SDS, 25% 2-mercaptoethanol, 10% glycerol and 1% bromophenol
blue, each sample of lysates was heated at 99 C for 10 min. SDS-
polyacrylamide gel electrophoresis was performed on a 5.4%
stacking gel with 10% separating gel. After electrophoresis, proteins
were transferred onto polyvinylidene diﬂuoride membrane. The
membrane was washed with Tris-buffered saline/Tween 20 and
blocked either with Blocking One (#03953-95, Nacalai Tesque,
Kyoto, Japan) for nNOS, DAX1 and b-actin, or with Blocking One-P
(#05999-84, Nacalai Tesque) for c-Jun N-terminal kinase (JNK)
and p38 MAPK, at 22e25 C for 1 h. The membrane was incubated
with rabbit anti-phospho-JNK antibody [phospho-SAPK/
JNK(Thr183/Tyr185), 1:1000; #9251, Cell Signaling Tech., Danvers,
MA, USA], rabbit anti-JNK antibody (1:1000; #9252, Cell Signaling
Tech.), rabbit anti-phospho-p38 MAPK antibody [phospho-p38
MAP kinase (Thr180/Tyr182), 1:1000; #9215S, Cell Signaling
Tech.], rabbit anti-p38 MAPK antibody (1:1000; #9212, Cell
Signaling Tech.), rabbit anti-nNOS antibody (1:1,000, #4234, Cell
Signaling Tech.), rabbit anti-DAX1 antibody (1:1000; #sc-841, Santa
Cruz Biotechnology, Inc.) andmouse anti-b-actin antibody (1:1,000,
#A5441, SigmaeAldrich) overnight at 4 C. After incubation with
horseradish peroxidase-conjugated secondary antibodies at
22e25 C for 1 h, bands were detected with ECL Select Western
blotting detection kit (#RPN2235, Amersham Biosciences, Piscat-
away, NJ, USA) on a lumino-imaging analyzer (LAS-3000mini, Fuji
Film, Tokyo, Japan).2.5. RT-PCR
Real-time PCR was performed with SYBR® Premix Ex Taq™
(#RR420S, TaKaRa) on a Chromo4™ real-time PCR analysis system
(Bio-Rad, Tokyo, Japan). Samples were run in duplicate. The ther-
mal cycling program consisted of 95 C for 3 min for polymerase
activation, and then 40 cycles of denaturation (95 C for 15 s) and
annealing and extension (60 C for 1 min). Data were analyzed by
the comparative Ct method. Glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) mRNA level was used as the internal control of
each sample. Primer sequences were nNOS forward 50-GGCAGA-
GATGAAAGATATGGG-30; nNOS reverse 50-GAATATGGGTTGTTG-
AGGACG-30; GAPDH forward 50-ACCATCTTCCAGGAGCGAGA-30;
GAPDH reverse 50-CAGTCTTCTGGGTGGCAGTG-30.2.6. siRNA transfection
SH-SY5Y cells in 6 well plates at a density of 6.0  104 cells/cm2
were transfected with 50 pmol DAX1 siRNA (#4390824, Life
Technologies) for 24 h, with the use of Lipofectamine RNAi MAX
(#13778030, Life Technologies) according to the manufacturer's
protocol. Then cells were washed with phosphate-buffered saline,
trypsinized and replated onto 35 mm dishes for subsequent
Western blotting and neurite outgrowth assay.
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Results are expressed as means ± SEM. Statistical signiﬁcance of
difference was evaluated with one-way ANOVA followed by Stu-
denteNewmaneKeuls test. Probability values less than 5% were
considered signiﬁcant.
3. Results
3.1. RAR stimulation induces neurite outgrowth that is suppressed
by inhibition of JNK, p38 MAPK and PI3K
Consistent with previous ﬁndings on retinoic acid by other in-
vestigators (13), stimulation of RARs by an agonist Am80 (300 nM)
for 24 h promoted neurite outgrowth in SH-SY5Y cells (Fig. 1A). We0
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been shown to prevent retinoic acid-induced neurite outgrowth in
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MAPK-mediated phosphorylation of HSP27 in SH-SY5Y cells (15).
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(20 mM), an inhibitor of MAPK/extracelluar signal-regulated kinase
(ERK) kinase (MEK). In this context, we have previously shown thatB
D
Am80 
*
*
0
50
100
150
200
250
300
350
400
450
0 hr 1 hr 3 hr 6 hr 12 hr 24 hr
p-
p3
8/
p3
8
(%
 o
f c
on
tr
ol
)
p-p38
p38
β-acƟn
Am80 (hr)
0            1            3            6          12          24
0
0.5
1
1.5
2
N
eu
rit
e
Le
ng
th
(fo
ld
 o
f c
on
tr
ol
)
n.s.
### ###
###
***
cont SP SB PD LY
Am80 
hotographs of SH-SY5Y cells treated with 300 nM Am80 for 24 h in the absence or the
cts of kinase inhibitors on Am80-induced neurite outgrowth. SP600125 (SP; 10 mM),
m 1 h before initiation of Am80 treatment and were present in medium during 24-h
***P < 0.001 vs. control; ###P < 0.001 vs. Am80 alone; n.s., not signiﬁcant vs. Am80
(D) in response to 300 nM Am80 applied for indicated periods. n ¼ 4 (C) and n ¼ 3 (D)
T. Fujibayashi et al. / Journal of Pharmacological Sciences 129 (2015) 119e126122this concentration of PD98059 efﬁciently blocked Am80-induced
expression of BDNF in rat midbrain slice cultures (6).
We next examined activation proﬁle of JNK and p38 MAPK
following Am80 application to SH-SY5Y cells. Increase in phos-
phorylated (activated) form of JNK exhibited an early component
that peaked at 3 h after initiation of Am80 treatment, and a late
component that reached a greater level at 24 h than the early
component (Fig.1C). On the other hand, the level of phosphorylated
p38MAPK increased gradually after Am80 treatment and reached a
peak at 12 h (Fig. 1D). Phosphorylation of ERK was also observed in
response to Am80 treatment (data not shown).
3.2. nNOS expression regulated by JNK, p38 MAPK and PI3K is
causally involved in neurite outgrowth
Because RAR stimulation increases expression of nNOS in rat
midbrain slice cultures (6) and several neuroblastoma cell lines
(8,9), we examined potential involvement of nNOS in the action of
Am80 in SH-SY5Y cells. 3-Bromo-7-nitroindazole, a selective in-
hibitor of nNOS among NOS isoforms, inhibits NOS activity in rat
cerebellar tissue supernatants by approximately 80% at a concen-
tration of 10 mM (16). As shown in Fig. 2A, neurite outgrowth
induced by 24-h application of 300 nM Am80 was signiﬁcantly
attenuated by 10e100 mM of 3-bromo-7-nitroindazole. Accord-
ingly, we examined the expression proﬁle of nNOS in response to
Am80 treatment. Increase in the expression level of nNOS protein
became prominent after Am80 treatment in a time-dependent
manner (Fig. 2B). Am80-induced increase in nNOS protein
expression was abolished by PI3K inhibition with 20 mM LY294002
(Fig. 2C). Inhibition of JNK and p38 MAPK by 10 mM SP600125 and
10 mM SB203580, respectively, also signiﬁcantly diminished Am80-
induced increase in nNOS protein expression, whereas a MEK in-
hibitor PD98059 (20 mM) did not show a signiﬁcant effect. We next
examined the level of nNOS mRNA by RT-PCR to determine
whether the counteracting effects of kinase inhibitors on nNOS
expression occurred at transcriptional level. Increase in nNOS
mRNA expression was observed in a time-dependent manner
(Fig. 2D), and the increase after 24-h treatment with Am80
(300 nM) was virtually abolished by LY294002 (Fig. 2E). In contrast,
SP600125, SB203580 and PD98059 showed no signiﬁcant inhibi-
tory effect on Am80-induced increase in nNOS mRNA (Fig. 2E).
These results suggest that PI3K regulates nNOS expression at
transcriptional level, whereas JNK and p38 MAPK do so at post-
transcriptional level.
3.3. DAX1 mediates RAR stimulation-induced nNOS up-regulation
and neurite outgrowth
A previous study on TGW-nu-I neuroblastoma cells has
demonstrated that up-regulation of a nuclear receptor DAX1 is
involved in induction of nNOS expression by retinoic acid (9).
Therefore, we addressed whether this could also be the case with
SH-SY5Y cells stimulated by Am80. We observed that the level of
DAX1 protein was increased in response to 300 nM Am80 treat-
ment for 12e24 h (Fig. 3A).
To reveal causal relationship between DAX1 up-regulation and
the actions of Am80, siRNA-mediated knockdown of DAX1 was
carried out in SH-SY5Y cells. Fig. 3B shows that our procedures for
siRNA transfection effectively suppressed Am80-induced increase
in DAX1. Two independent sets of experiments conﬁrmed that
DAX1 protein level in cells treated with 300 nM Am80 for 24 h was
1.46 fold higher than that in vehicle-treated cells, whereas DAX1
siRNA limited DAX1 protein level in Am80-treated cells to 1.01 fold
of that of vehicle-treated cells. Importantly, DAX1 knockdown
abrogated Am80-induced increase in nNOS expression (Fig. 3C).Moreover, Am80-induced neurite outgrowth was also signiﬁcantly
attenuated by DAX1 knockdown (Fig. 3D and E). These results
suggest that DAX1 is a key signaling component mediating neurite
outgrowth as well as nNOS up-regulation by RAR stimulation.
3.4. PI3K activation mediates activation of JNK and p38 MAPK by
RAR stimulation
Results so far indicate that JNK, p38 MAPK and PI3K activated by
RAR stimulation regulates nNOS up-regulation. In a ﬁnal set of
experiments, we addressed relationship between activation of PI3K
and activation of MAPKs. Results of Western blot analysis showed
that inhibition of PI3K by LY294002 blocked Am80-induced phos-
phorylation of JNK and p38 MAPK (Fig. 4), suggesting that PI3K acts
upstream of these MAPKs in RAR signaling cascade.
4. Discussion
RAR stimulation has long been known to trigger differentiation
of neuroblastoma cells into neuronal phenotype, which is charac-
terized by establishment of neuron-like morphology associated
with neurite outgrowth (10,13). On the other hand, RAR stimulation
has also been reported to induce up-regulation of nNOS in several
neuronal cell types (8,9). In the present study we demonstrated for
the ﬁrst time that nNOS up-regulation is causally involved in RAR
stimulation-induced neurite outgrowth.
An RAR agonist Am80 was able to induce neurite outgrowth at
a concentration of 300 nM, a much lower concentration than that
used in previous studies (10 mM) demonstrating neurite
outgrowth-promoting activity of Am80 on NH-12 cells (17) and
SH-SY5Y cells (18). With regard to RAR stimulation-induced neu-
rite outgrowth, involvement of several signaling pathways has
already been proposed in SH-SY5Y cells. For example, retinoic
acid-induced neurite outgrowth was abolished by a PI3K inhibitor
LY294002 (11) or by overexpression of dominant negative SEK1, an
upstream kinase of JNK (10). On the other hand, MEK inhibitor
U0126 failed to block retinoic acid-induced neurite outgrowth
(13). Our present results are consistent with these previous re-
ports. Additionally, we demonstrated that p38 MAPK was acti-
vated by Am80 and was involved in promotion of neurite
outgrowth in SH-SY5Y cells. In this context, a previous study has
reported that p38 MAPK is not involved in retinoic acid-induced
neurite outgrowth in MN9D dopaminergic neuronal cell line
(14), whereas involvement of p38 MAPK in retinoic acid-induced
neurite outgrowth has been demonstrated in rat retinal photore-
ceptor cells (19).
What we found newly here is that nNOS up-regulation is inti-
mately linked with RAR stimulation-induced neurite outgrowth.
That is, nNOS inhibition by 3-bromo-7-nitroindazole signiﬁcantly,
though not completely, attenuated the effect of Am80. NO derived
from constitutive NOSmay regulate various physiological processes
in neural cells as well as in non-neural cells (20), and retinoic acid-
induced increase in NO production or nNOS expression has been
observed in several other cell lines (8,9), but relationship between
nNOS and neurite outgrowth has not been reported so far. On the
other hand, NO per se has been shown to mediate neurite
outgrowth in neuron-like cell lines such as PC12 cells treated with
nerve growth factor (21) and NG108-15 cells treated with angio-
tensin II (22). Therefore, similar mechanisms may be recruited by
RAR stimulation in SH-SY5Y cells.
Interestingly, kinases involved in RAR stimulation-induced
neurite outgrowth such as PI3K, JNK and p38 MAPK were also
shown to regulate nNOS up-regulation. In other words, the sup-
pressive effects of kinase inhibitors on Am80-induced neurite
outgrowth seem to be attributable to their suppressive effects on
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T. Fujibayashi et al. / Journal of Pharmacological Sciences 129 (2015) 119e126 123nNOS expression. PI3K mediates retinoic acid-induced up-regula-
tion of nNOS in TGW-nu-I neuroblastoma cells (9), which is
consistent with our present results. In contrast, regulation of nNOS
up-regulation by JNK and p38 MAPK is a novel ﬁnding of the pre-
sent study, and indeed, the study by Nagl et al. (9) reported that
SP600125 did not prevent nNOS up-regulation. Therefore, roles of
MAPKs in regulation of nNOS expression may be dependent on
speciﬁc cellular contexts and may be different among different cell
types. Notably, regulation of nNOS expression by JNK and p38MAPK seems to be effective at post-transcriptional level, as the
expression level of nNOS mRNA was not signiﬁcantly altered by
inhibition of these kinases. These observations are in sharp contrast
with the results of PI3K inhibition, where up-regulation of nNOS
mRNA by Am80 was virtually abolished by LY294002.
DAX1 is an orphan nuclear receptor that has been reported to
regulate various systemic functions such as sexual development,
steroidogenesis and neural differentiation (23). In TGW-nu-I cells,
retinoic acid-induced nNOS up-regulation has been shown to
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T. Fujibayashi et al. / Journal of Pharmacological Sciences 129 (2015) 119e126124require increased expression of DAX1 that is induced in a PI3K-
dependent manner (9). Our present results conﬁrm that RAR
stimulation by Am80 increases DAX1 expression. Crucial involve-
ment of DAX1 in nNOS expression was also conﬁrmed by knock-
down experiments, where inhibition of DAX1 expression
abrogated Am80-induced nNOS up-regulation. In addition, we
observed that DAX1 knockdown attenuated neurite outgrowth
induced by Am80. These results are consistent with the notion that
nNOS expression induced in a DAX1-dependent manner underlies
RAR-mediated promotion of neurite outgrowth. The results also
reveal a novel example showing that DAX1 can regulate neurite
outgrowth.
Finally, we examined relationship between PI3K and MAPKs.
Suppression of activation of JNK and p38 MAPK by LY294002
strongly suggests that recruitment of MAPKs is regulated by
PI3K. In this context, JNK activation as a downstream event ofPI3K activity has been demonstrated in m-opioid receptor-
coupled signaling in SH-SY5Y cells (24). On the other hand, the
mechanistic link between PI3K and p38 MAPK activation re-
mains to be determined, because PI3K inhibition (rather than
activation) has generally been known to accompany p38 MAPK
activation (25).
Overall, our results demonstrated that RAR stimulation induced
nNOS expression via recruitment of multiple kinases, which
contributed to promotion of neurite outgrowth. Provided that
increased DAX1 expression depends on PI3K activation (9), we
propose here that JNK and p38 MAPK constitute an additional
signaling pathway downstream of PI3K to regulate nNOS expres-
sion at a post-transcriptional level (Fig. 5). Whether corresponding
signaling mechanisms play a role in mediating actions of retinoids
in the central nervous system is an interesting issue to be deter-
mined in further investigations.
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Fig. 4. PI3K acts upstream of JNK and p38 MAPK in RAR stimulation-triggered signaling. Shown are the results of Western blot analysis on JNK activation (A) and p38 MAPK
activation (B). LY294002 (20 mM) was applied from 1 h before initiation of Am80 treatment and was present in medium during 24-h treatment with 300 nM Am80. n ¼ 4 (A) and
n ¼ 5 (B) for each condition. *P < 0.05 vs. control; #P < 0.05, ##P < 0.01 vs. Am80 alone.
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Fig. 5. Proposed mechanisms of RAR signaling involved in nNOS up-regulation and
neurite outgrowth in SH-SY5Y cells. Increased nNOS expression is essential for RAR
stimulation to fully promote neurite outgrowth. In addition, involvement of JNK, p38
MAPK and PI3K in RAR-mediated neurite outgrowth is attributable to the regulation by
these kinases of nNOS up-regulation. PI3K may be fundamentally involved in nNOS up-
regulation via recruitment of nuclear receptor DAX1, as reported previously in another
neuronal cell line (9). PI3K also triggers activation of JNK and p38 MAPK, and these
MAPKs may regulate nNOS protein expression at post-transcriptional level.
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